Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT01735981
Other study ID # 2008H0109
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date June 2008
Est. completion date June 2012

Study information

Verified date July 2021
Source Ohio State University
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

To examine the benefits of using a video-game, Dance, Dance, Revolution, as an exercise modality to improve gait and balance in individuals with Huntington's disease.


Description:

The primary purpose of this study was to determine the effectiveness of a therapist-guided Video-game Biofeedback Modulated Exercise (ViBE) program administered via Dance Dance Revolution to improve dynamic balance, gait and mobility in individuals with Huntington's Disease. Secondary aims were to explore whether the ViBE intervention would improve quality of life, fall risk, and neuropsychological functions. The investigators hypothesized that the video-game program would lead to greater improvements in walking, dynamic balance, quality of life, fall risk, and neuropsychological function than a control handheld video game program. Since motivation is essential to the long-term maintenance of an exercise program the investigators were also interested in finding out how successful people with Huntington's Disease were at playing Dance Dance Revolution, what their perceptions were of playing the game, and whether they thought that it was beneficial


Recruitment information / eligibility

Status Completed
Enrollment 24
Est. completion date June 2012
Est. primary completion date November 2010
Accepts healthy volunteers No
Gender All
Age group 18 Years to 79 Years
Eligibility Inclusion Criteria: - adults 18 - 79 with a diagnosis of Huntington's disease Exclusion Criteria: - cannot walk 10 feet without assistance, any other neurologic condition

Study Design


Related Conditions & MeSH terms


Intervention

Other:
Video game exercise using Dance Dance Revolution
use of the video-game, Dance, Dance Revolution as an exercise to improve gait and balance
hand-held video game
hand-held video games

Locations

Country Name City State
United States The Ohio State University Atwell Hall Columbus Ohio

Sponsors (1)

Lead Sponsor Collaborator
Anne Kloos

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Gait Parameters utilized GAITRite to obtain spatiotemporal measures of gait: forward velocity. 6 weeks
Primary Gait Parameters utilized GAITRite to obtain spatiotemporal measures of gait: forward stride length. 6 weeks
Primary Gait Parameters utilized GAITRite to obtain spatiotemporal measures of gait: forward swing percent. 6 weeks
Primary Gait Parameters utilized GAITRite to obtain spatiotemporal measures of gait: forward double support percent. 6 weeks
Primary Gait Parameters utilized GAITRite to obtain spatiotemporal measures of gait: forward heel to heel base of support. 6 weeks
Primary Gait Parameters utilized GAITRite to obtain spatiotemporal measures of gait: backwards velocity. 6 weeks
Primary Gait Parameters utilized GAITRite to obtain spatiotemporal measures of gait: backwards stride length. 6 weeks
Primary Gait Parameters utilized GAITRite to obtain spatiotemporal measures of gait: backwards swing percent. 6 weeks
Primary Gait Parameters utilized GAITRite to obtain spatiotemporal measures of gait: backwards double support percent. 6 weeks
Primary Gait Parameters utilized GAITRite to obtain spatiotemporal measures of gait: backwards heel to heel base of support. 6 weeks
Primary Gait Parameters utilized GAITRite to obtain spatiotemporal measures of gait: obstacle velocity. 6 weeks
Secondary Tinetti Mobility Test Observation of gait and balance with quantifiable 16-item assessment with an ordinal scale of 0-2 for up to a total score of 32, with higher scores indicating better performance. It is reliable and predicts falls among those with Parkinson's disease and Huntington's disease. 6 weeks
Secondary Four Square Step Test Examines ability to step over an object in multiple directions and is timed. Participants are instructed to step over a cane into each square in a specific order. Faster times indicate better balance. It has been shown to predict falls in the elderly. 6 weeks
Secondary Activities-Specific Balance Confidence Scale Individuals rate their balance confidence from 1-100 on 16 tasks and total score is the mean; higher scores indicate greater confidence and lower fall risk. The Activities-Specific Balance Confidence Scale is reliable and valid in elderly and neurological populations. 6 weeks
Secondary World Health Organization Quality of Life This questionnaire is a measure of quality of life addressing 4 domains including physical, psychological, social, and environment health. Responses on 26 items are on a five-point scale (from 1 = very dissatisfied to 5 = very satisfied) and each item is added to achieve a total score for each domain. The mean score for each domain is calculated then multiplied by 4 to get the domain score which are then transformed to a scaled score of 0-100 comparable to the original WHOQOL-100 therefore a total score between 0-400 with high scores indicating better quality of life. The WHOQOLBref has good reliability and validity. post intervention and post hand-held game, each lasts 6 weeks
See also
  Status Clinical Trial Phase
Recruiting NCT04120493 - Safety and Proof-of-Concept (POC) Study With AMT-130 in Adults With Early Manifest Huntington's Disease Phase 1/Phase 2
Completed NCT02956148 - Follow-up Measurement of Brain PDE10A Enzyme Levels in Huntington´s Disease Gene Expansion Carriers Early Phase 1
Terminated NCT02494778 - A Study Evaluating if Pridopidine is Safe, Efficacious, and Tolerable in Patients With Huntington's Disease Phase 2
Completed NCT02197130 - Randomized, Placebo Controlled Study Of The Efficacy And Safety Of PF-02545920 In Subjects With Huntington's Disease Phase 2
Completed NCT02208934 - Study To Assess the Safety and Tolerability of Single Ascending Oral Doses of PBF-999 in Healthy Young Male Volunteers Phase 1
Completed NCT02216474 - Brain Stimulation in Movement Disorders N/A
Completed NCT01806896 - Study Evaluating The Safety, Tolerability And Brain Function Of 2 Doses Of PF-0254920 In Subjects With Early Huntington's Disease Phase 2
Completed NCT01502046 - Neuroprotection by Cannabinoids in Huntington's Disease Phase 2
Terminated NCT00712426 - Creatine Safety, Tolerability, & Efficacy in Huntington's Disease (CREST-E) Phase 3
Completed NCT00670709 - Examination of Quantitative Electroencephalographic (QEEG) Biomarkers in Huntington's Disease
Completed NCT00029874 - Minocycline in Patients With Huntington's Disease Phase 1/Phase 2
Terminated NCT02231580 - Study Exploring Safety, Pharmacokinetic and Pharmacodynamic of BN82451 in Male Huntington's Disease Patients Phase 2
Completed NCT02215616 - A Clinical Study in Participants With Huntington's Disease (HD) to Assess Efficacy and Safety of Three Oral Doses of Laquinimod Phase 2
Not yet recruiting NCT02551705 - Functional Imaging of Social Cognition in Premanifest Huntington's Disease N/A
Active, not recruiting NCT02101957 - Multicentric Trial of the Treatment of Huntington's Disease by Cysteamine (RP103) Phase 2/Phase 3
Completed NCT00990613 - A Study Evaluating The Absorption Of Dimebon Into The Body From A Dimebon Solution Applied To The Skin Phase 1
Completed NCT00975481 - A Study To Evaluate The Abuse Potential Of Single Oral Doses Of Dimebon (Latrepirdine) In Healthy Recreational Polydrug Users Phase 1
Completed NCT01521832 - Escalating Dose Study in Healthy Volunteers With SEN0014196 Phase 1
Completed NCT00387270 - Safety Study of the Novel Drug Dimebon to Treat Patients With Huntington's Disease Phase 1/Phase 2
Completed NCT00095355 - Effects of Lithium and Divalproex`on Brain-Derived Neurotrophic Factor in Huntington's Disease Phase 2